Gravallese, E. M. & Firestein, G. S. Rheumatoid arthritis — common origins, divergent mechanisms. N. Engl. J. Med. 388, 529–542 (2023).

Article  CAS  PubMed  Google Scholar 

Abend, A. H. et al. Estimation of prevalence of autoimmune diseases in the United States using electronic health record data. J. Clin. Invest. 135, e178722 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Safiri, S. et al. Global, regional and national burden of rheumatoid arthritis 1990–2017: a systematic analysis of the Global Burden of Disease study 2017. Ann. Rheum. Dis. 78, 1463–1471 (2019).

Article  PubMed  Google Scholar 

Upchurch, K. S. & Kay, J. Evolution of treatment for rheumatoid arthritis. Rheumatology 51, vi28–vi36 (2012).

Article  CAS  PubMed  Google Scholar 

Black, R. J. et al. Mortality estimates and excess mortality in rheumatoid arthritis. Rheumatology 62, 3576–3583 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Holmqvist, M., Ljung, L. & Askling, J. Mortality following new-onset rheumatoid arthritis: has modern rheumatology had an impact? Ann. Rheum. Dis. 77, 85–91 (2018).

Article  PubMed  Google Scholar 

Johnson, T. M. et al. A narrowing mortality gap: temporal trends of cause-specific mortality in a national matched cohort study in US veterans with rheumatoid arthritis. Arthritis Care Res. 75, 1648–1658 (2023).

Article  Google Scholar 

Nikiphorou, E. et al. Secular changes in clinical features at presentation of rheumatoid arthritis: increase in comorbidity but improved inflammatory states. Arthritis Care Res. 69, 21–27 (2017).

Article  CAS  Google Scholar 

Crowson, C. S. et al. Comorbidity clusters in patients with rheumatoid arthritis identify a patient phenotype with a favourable prognosis. Ann. Rheum. Dis. 83, 556–563 (2024).

Article  PubMed  PubMed Central  Google Scholar 

England, B. R. et al. Influence of multimorbidity on new treatment initiation and achieving target disease activity thresholds in active rheumatoid arthritis: a cohort study using the Rheumatology Informatics System for Effectiveness registry. Arthritis Care Res. 75, 231–239 (2023).

Article  CAS  Google Scholar 

Crowson, C. S. et al. Comprehensive assessment of multimorbidity burden in a population-based cohort of patients with rheumatoid arthritis. RMD Open 8, e002022 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Gunderson, T. M., Myasoedova, E., Davis, J. M. III & Crowson, C. S. Multimorbidity burden in rheumatoid arthritis: a population-based cohort study. J. Rheumatol. 48, 1648–1654 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Radner, H., Yoshida, K., Smolen, J. S. & Solomon, D. H. Multimorbidity and rheumatic conditions — enhancing the concept of comorbidity. Nat. Rev. Rheumatol. 10, 252–256 (2014).

Article  PubMed  Google Scholar 

England, B. R. et al. Burden and trajectory of multimorbidity in rheumatoid arthritis: a matched cohort study from 2006 to 2015. Ann. Rheum. Dis. 80, 286–292 (2021).

Article  CAS  PubMed  Google Scholar 

England, B. R. et al. Identification of multimorbidity patterns in rheumatoid arthritis through machine learning. Arthritis Care Res. 75, 220–230 (2023).

Article  CAS  Google Scholar 

Batko, B. et al. Comorbidity in incident rheumatoid arthritis: a nationwide case–control study with bidirectional follow-up. Rheumatology 64, 3370–3378 (2025).

Article  PubMed  PubMed Central  Google Scholar 

Dutt, S. et al. Multimorbidity patterns and rheumatoid arthritis disease outcomes: findings from a multicenter, prospective cohort. Arthritis Care Res. 77, 337–348 (2025).

Article  Google Scholar 

Holers, V. M. et al. Distinct mucosal endotypes as initiators and drivers of rheumatoid arthritis. Nat. Rev. Rheumatol. 20, 601–613 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kimbrough, B. A. et al. Decline in incidence of extra-articular manifestations of rheumatoid arthritis: a population-based cohort study. Arthritis Care Res. 76, 454–462 (2024).

Article  CAS  Google Scholar 

Ljung, L. et al. Incidence and predisposing factors of extra-articular manifestations in contemporary rheumatoid arthritis. Eur. J. Intern. Med. 126, 95–101 (2024).

Article  PubMed  Google Scholar 

Conforti, A. et al. Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmun. Rev. 20, 102735 (2021).

Article  PubMed  Google Scholar 

Rodas Flores, J. L. et al. Neutropenia and Felty syndrome in the twenty-first century: redefining ancient concepts in rheumatoid arthritis patients. J. Clin. Med. 13, 7677 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samhouri, B. F. et al. Incidence, risk factors, and mortality of clinical and subclinical rheumatoid arthritis-associated interstitial lung disease: a population-based cohort. Arthritis Care Res. 74, 2042–2049 (2022).

Article  CAS  Google Scholar 

Brooks, R. et al. The impact of disease severity measures on survival in U.S. veterans with rheumatoid arthritis-associated interstitial lung disease. Rheumatology 61, 4667–4677 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Farquhar, H. J. et al. Survival of adults with rheumatoid arthritis associated interstitial lung disease — a systematic review and meta-analysis. Semin. Arthritis Rheum. 60, 152187 (2023).

Article  CAS  PubMed  Google Scholar 

Provan, S. A. et al. Interstitial lung disease in patients with rheumatoid arthritis or psoriatic arthritis initiating biologics and controls: data from 5 Nordic registries. J. Rheumatol. 51, 1111–1118 (2024).

Article  CAS  PubMed  Google Scholar 

Matson, S. M. et al. Treatment outcomes for rheumatoid arthritis-associated interstitial lung disease: a real-world, multisite study of the impact of immunosuppression on pulmonary function trajectory. Chest 163, 861–869 (2023).

Article  CAS  PubMed  Google Scholar 

England, B. R. et al. Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease: a retrospective, active-comparator, new-user, cohort study. Lancet Rheumatol. 7, e166–e177 (2025).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matteson, E. L. et al. Nintedanib in patients with autoimmune disease-related progressive fibrosing interstitial lung diseases: subgroup analysis of the INBUILD trial. Arthritis Rheumatol. 74, 1039–1047 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Solomon, J. J. et al. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study. Lancet Resp. Med. 11, 87–96 (2023).

Article  CAS  Google Scholar 

Maher, T. M. et al. Nerandomilast in patients with progressive pulmonary fibrosis. N. Engl. J. Med. 392, 2203–2214 (2025).

Article  CAS  PubMed  Google Scholar 

Johnson, S. R. et al. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) guideline for the screening and monitoring of interstitial lung disease in people with systemic autoimmune rheumatic diseases. Arthritis Care Res. 76, 1070–1082 (2024).

Article  Google Scholar 

Antoniou K. M. et al. ERS/EULAR clinical practice guidelines for connective tissue diseases associated interstitial lung disease. Ann. Rheum. Dis. 85, 22–60 (2026).

Article  PubMed  Google Scholar 

Kronzer, V. L. et al. Autoantibodies against citrullinated and native proteins and prediction of rheumatoid arthritis-associated interstitial lung disease: a nested case–control study. Lancet Rheumatol. 5, e77